Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients-Reference-Cited by-同舟云学术

Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients

Published:2022-10-18 Issue:6 Volume:91 Page:872-882
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Lehrer Eric J.,Gurewitz Jason,Bernstein Kenneth,Kondziolka Douglas,Fakhoury Kareem R.,Rusthoven Chad G.,Niranjan Ajay,Wei Zhishuo,Lunsford L. Dade,Malouff Timothy D.,Ruiz-Garcia Henry,Peterson Jennifer L.,Bonney Phillip,Hwang Lindsay,Yu Cheng,Zada Gabriel,Deibert Christopher P.,Prasad Rahul N.,Raval Raju R.,Palmer Joshua D.,Patel Samir,Picozzi Piero,Franzini Andrea,Attuati Luca,Mathieu David,Trudel Claire,Lee Cheng-chia,Yang Huai-che,Jones Brianna M.,Green Sheryl,Ahluwalia Manmeet S.,Sheehan Jason P.,Trifiletti Daniel M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Reference30 articles.

1. Epidemiology of synchronous brain metastases;Singh;Neurooncol Adv.,2020

2. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med.,2016

3. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial;Hodi;Lancet Oncol.,2016

4. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial;Hodi;Lancet Oncol.,2018

5. Combined nivolumab and ipilimumab in melanoma metastatic to the brain;Tawbi;N Engl J Med.,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation and Melanoma: Where Are We Now?;Current Oncology Reports;2024-06-01

2. Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches;Journal of Neuro-Oncology;2024-04-17

3. Symptomatic brain metastases in melanoma;Experimental Dermatology;2024-04

4. Role of radiotherapy in the management of brain oligometastases;Cancer/Radiothérapie;2024-02

5. Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities;Journal of Hematology & Oncology;2023-12-16